Skip to main content
Figure 4 | BMC Pharmacology and Toxicology

Figure 4

From: Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy

Figure 4

Median concentration-time profile of boosted lopinavir administered with two different doses of rifabutin. The median lopinavir (LPV) concentrations for 14 patients administered 2 different concentrations of rifabutin (RBT). Blue line corresponds to a RBT dose of 150 mg daily and the purple line to 150 mg tiw. LPV/r corresponds to boosted lopinavir. The bars represent interquartile range (IQR).

Back to article page